首页> 美国卫生研究院文献>The Journal of Automatic Chemistry >RP-HPLC Method Development and Its Validation for Quantitative Determination of Rimonabant in Human Plasma
【2h】

RP-HPLC Method Development and Its Validation for Quantitative Determination of Rimonabant in Human Plasma

机译:RP-HPLC方法的建立及其定量测定人血浆中利莫那班的有效性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

A simple, accurate, and precise HPLC method was developed and validated for determination of rimonabant in human plasma. Following liquid-liquid extraction, chromatographic separation was accomplished using C18 column with mobile phase consisting of acetonitrile : water (90 : 10, v/v), drug was detected at 260 nm using UVdetector. The LOD and LOQ were 3.0 and 10.0 μg/L, respectively. The method is linear in the interval 50.0–1000.0 μg/L. The average extraction recovery of drug from plasma was found to be 92.2%. The percent CV of the method was found to be less than 10.8%, and accuracy was found between 94.5 and 106.7%. The assay may be applied to a pharmacokinetic and bioequivalence study of rimonabant.
机译:开发了一种简单,准确和精确的HPLC方法,并经过验证,可用于测定人血浆中的利莫那班。液-液萃取后,使用带乙腈:水(90∶∶ with10,v / v)流动相的C18色谱柱进行色谱分离,使用紫外检测器在260nm处检测药物。 LOD和LOQ分别为3.0和10.0μg/ L。该方法在50.0-1000.0μg/ L范围内是线性的。发现从血浆中提取药物的平均回收率为92.2%。发现该方法的CV百分比小于10.8%,并且发现的准确度在94.5至106.7%之间。该测定法可用于利莫那班的药代动力学和生物等效性研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号